|
Frequencies of FCGR3A and FCGR2A genotypes in patients with RA and positive and negative for anti-GPI antibodies |
||||||
| FCGR3A-158 |
FCGR2A-131 |
|||||
|
|
||||||
| FF low |
F/V |
VV high |
HH high |
H/R |
RR low |
|
|
|
||||||
| GPI+ RA (n = 23) |
10 (43.5) |
9 (39.1) |
4 (17.4) |
16 (69.6) |
6 (26.1) |
1 (4.3) |
| GPI- RA (n = 164) |
86 (52.4) |
68 (41.5) |
10 (6.1) |
128 (78) |
29 (17.7) |
7 (4.3) |
| GPI+ Control (n = 9) |
8(88.9) |
1 (11.1) |
0 (0) |
4 (44.4) |
5 (55.6) |
0 (0) |
| GPI- Control (n = 149) |
83 (55.7) |
58 (38.9) |
8 (5.4) |
109 (73.2) |
40 (26.8) |
0 (0) |
|
Data are expressed as number (percentage) of individuals. GPI, glucose-6-phosphate isomerase; high, high affinity genotype; low, low affinity genotype; RA, rheumatoid arthritis. | ||||||
Matsumoto et al. Arthritis Research & Therapy 2005 7:R1183 doi:10.1186/ar1802 |
||||||